Founded by cardiologists for cardiologists: of course we’re looking forward to learning and connecting at TCT 2023.

Blog, Cardiology & Cardiothoracic, Conferences, Events, GCMI, News, Physician Innovators, Preclinical CRO Excellence

The Transcatheter Cardiovascular Therapeutics (TCT) meeting is the world’s largest educational meeting specializing in interventional cardiovascular medicine. This year, it will take place on October 23-26, 2023 back in San Francisco, California.   “We look forward to connecting with sponsors, clinician innovators and regulatory officials at TCT 2023 to further understand the latest in transcatheter…

The GCMI 2023 State of Medtech Design and Development Report: Part 1

Accelerator, Blog, Cardiology & Cardiothoracic, Design & Development, Digital Health, GCMI, How GCMI Supports Georgia Tech Innovators, Researchers, PIs and Students, News, Physician Innovators, Preclinical CRO Excellence

Innovation in medical technologies is something of a paradox. On one hand, new technologies that drive innovation can manifest at breakneck speed. On the other hand, the pace at which those technologies breed innovations that reach full commercialization and patient impact can be glacial by comparison.   What have been the most significant changes with…

Consolidation, Planning and Due Diligence: Our Annual Spotlight on the State of Preclinical for 2023

Bio-skills and medical device training, Blog, Cardiology & Cardiothoracic, GCMI, neurology, News, orthopedic, Preclinical CRO Excellence, Regenerative Medicine, spine, T3

GCMI and our preclinical arm also known as T3 Labs is a trusted, proven industry-leading preclinical CRO for medical devices and other medical products. We’re an AAALAC accredited facility that conducts feasibility, proof of concept, feasibility, and safety and efficacy GLP medical device testing for studies in any therapeutic area and in small and large…

Let’s Talk Innovation, Including Preclinical for Artificial Organ Technologies, at ASAIO 2023

Blog, Cardiology & Cardiothoracic, News, Physician Innovators, Preclinical CRO Excellence

Evaluating your new artificial organ technology’s readiness for preclinical work or just want to get together to talk about the latest in preclinical testing, bioskills training or medtech innovation across the board? Connect with GCMI and T3 Labs at ASAIO 2023. At GCMI, medtech and medical device innovation are at the core of our efforts…

Preclinical Implications for Existing, and New Circulatory Assist Devices

Blog, Cardiology & Cardiothoracic, GCMI, News, Physician Innovators, Preclinical CRO Excellence

The National Center for Biotechnology Information describes mechanical circulatory assist devices as, “commonly used in the treatment of severe heart failure as bridges to cardiac transplant, as destination therapy for patients who are not transplant candidates, and as bridges to recovery and “decision-making.” These devices, which can be used to support the left or right…

Cardiothoracic Colleagues: Catch up on preclinical and more with GCMI at AATS 2023

Blog, Cardiology & Cardiothoracic, Conferences, Preclinical CRO Excellence

“Founded in 1917, the American Association for Thoracic Surgery (AATS), along with its philanthropic arm, the AATS Foundation, has sought to advance the field of cardiothoracic surgery. It is an international organization whose members have a proven record of distinction within the specialty and have made significant contributions to the care and treatment of cardiothoracic…

Onsite State-of-the-Art CT Scanner Adds Capability, Efficiency, Time and Cost-Savings for GCMI Preclinical Customers

Blog, Cardiology & Cardiothoracic, GCMI, neurology, orthopedic, Preclinical CRO Excellence

Image credit: Clinical Imaging Systems GCMI, the U.S. proving ground for medtech innovation, has recently acquired a GE LightSpeed VCT 64 Slice CT Scanner with cardiac gating capabilities. “The ability for these machines to generate 3D images of anatomic structures and organs in a pre-op, post-op or intra-operative scenario, including cardiac and vascular imaging, has…

Beware the Unfamiliar Approach: Preclinical Implications for Novel Cell & Gene Therapies

Blog, Cardiology & Cardiothoracic, GCMI, orthopedic, Pediatric, Physician Innovators, Preclinical CRO Excellence, Regenerative Medicine, spine, T3

Roughly one decade ago, scientists made significant improvements in viral vectors’ ability to deliver genetic therapeutics. Those therapies use genetic material like DNA to manipulate a patients’ own cells. Cellular (cell) therapies transfer cells into the patient whether they are the patients’ own cells or cells derived from another location or donor cells.    Because…

Who brings what to the table? Artivion’s Deepal Stevenson, M.S. shares her insights on the client / CRO relationship for effective, efficient preclinical studies and reports.

Blog, Cardiology & Cardiothoracic, GCMI, neurology, News, orthopedic, Physician Innovators, Preclinical CRO Excellence, Regenerative Medicine, spine, T3

Life science companies of all shapes and sizes rely on preclinical contract research organizations (CROs) to generate the data and reports required to bring their innovations to market.   To do this effectively, and in a capital efficient manner, each entity needs to understand what they need from the other, when they need it, why…